Business Description
Curasight AS
SIC : 3826
ISIN : DK0061295797
Share Class Description:
XSAT:CURAS: Ordinary SharesTotal Employee Number:
4Compare
Compare
Traded in other countries / regions
CURAS.SwedenCUS.Germany IPO Date
2020-10-08Description
Curasight AS is a clinical-stage radiopharmaceutical company based in Copenhagen, Denmark, developing uTREAT, a first-in-class uPAR-targeted radioligand therapy (RLT) platform designed to treat aggressive solid tumors. The Company is focused on advancing its diagnostic and therapeutic platforms through key clinical milestones.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.27 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -34.4 | |||||
3-Year EPS without NRI Growth Rate | -27.7 | |||||
3-Year FCF Growth Rate | -16.3 | |||||
3-Year Book Growth Rate | -39.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.58 | |||||
9-Day RSI | 40.97 | |||||
14-Day RSI | 37.25 | |||||
3-1 Month Momentum % | -20.24 | |||||
6-1 Month Momentum % | 4.04 | |||||
12-1 Month Momentum % | 248.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 1 | |||||
Days Payable | 40.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -312.89 | |||||
ROA % | -124.68 | |||||
ROIC % | -463.16 | |||||
3-Year ROIIC % | -145.14 | |||||
ROCE % | -321.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 31.89 | |||||
Price-to-Tangible-Book | 51.68 | |||||
EV-to-EBIT | -8.09 | |||||
EV-to-EBITDA | -8.16 | |||||
EV-to-FCF | -6.56 | |||||
| Price-to-Net-Current-Asset-Value | 51.68 | |||||
Earnings Yield (Greenblatt) % | -12.37 | |||||
FCF Yield % | -12.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Curasight AS Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -1.162 | ||
| Beta | 1.7603 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.59 | ||
| Volatility % | 99.51 | ||
| 14-Day RSI | 37.25 | ||
| 14-Day ATR (kr) | 1.455154 | ||
| 20-Day SMA (kr) | 11.233 | ||
| 12-1 Month Momentum % | 248.96 | ||
| 52-Week Range (kr) | 3.8 - 25 | ||
| Shares Outstanding (Mil) | 49.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Curasight AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Curasight AS Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-26 | In 161 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 161 days | ||
| Third quarter earnings results for 2026 | 2026-11-26 | In 69 days | ||
| Second quarter earnings results for 2026 | 2026-08-27 | 15.25 (+2.69%) | ||
| First quarter earnings results for 2026 | 2026-05-28 | 15.65 (-6.29%) | ||
| General meeting for 2026 | 2026-03-25 10:00 | 14.90 (+2.41%) | ||
| Curasight to present at TD Cowen\'s 46th Annual Health Care Conference in Boston | 2026-03-03 11:50 | 16.55 (+2.16%) | ||
| Annual report for 2025 | 2026-02-26 | 16.45 (-1.79%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 16.45 (-1.79%) | ||
| Third quarter earnings results for 2025 | 2025-11-27 | 6.50 (+0.00%) |
Show
Entries
Curasight AS Frequently Asked Questions
What is Curasight AS(XSAT:CURAS)'s stock price today?
The current price of XSAT:CURAS is kr9.82. The 52 week high of XSAT:CURAS is kr25.00 and 52 week low is kr3.80.
When is next earnings date of Curasight AS(XSAT:CURAS)?
The next earnings date of Curasight AS(XSAT:CURAS) is 2026-11-26.
Does Curasight AS(XSAT:CURAS) pay dividends? If so, how much?
Curasight AS(XSAT:CURAS) does not pay dividend.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers